Disruptor Profile: Day Zero Diagnostics, Inc.

Day Zero Diagnostics Inc. is a medical technology company, which is developing a new class of diagnostics, including whole genome sequencing-based diagnostics, for modernizing the diagnosis and treatment of infectious disease using genome sequencing and machine learning (ML) technologies.

Scope

The report provides information and insights into Day Zero Diagnostics, Inc.'s, including -

- Overview of the company and its product offering

- Detailed insight into its business model, company type and headquarter

- Information on funding

- Biography of top management

Reasons to buy

- Gain insights into Day Zero Diagnostics Inc.’s business operations.

- Gain insights into fundings

- Gain understanding about its technology focus.

Companies mentioned

Sands Capital Ventures LLC

Golden Seeds LLC

TriVentures L.P.

National Institute of Allergies

Infectious Disease (NIAID)

Sands Capital Ventures LLC

Golden Seeds LLC

TriVentures L.P.

National Institute of Allergies

Infectious Disease (NIAID)

Table of Contents

Table of contents

Company Overview

Technology Focus

Product Overview

Funding

Key Employees

Appendix

Table of contents

Company Overview

Technology Focus

Product Overview

Funding

Key Employees

Appendix

List of Tables

List of Figures

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports

We use GlobalData every day throughout the organisation – just try taking it away from us!

  Idox